Moderna’s Covid-19 vaccine Spikevax was recently approved by the Food and Drug Administration (FDA) to be used for children six to 11 years old in the country.
FDA Recently, the FDA amended the emergency use authorization (EUA) filed by Zuellig Pharma Corporation, through its commercialization a